Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2002-10-01 (23 years)Status: ActiveBusiness sector: Fabrication de matériel médico-chirurgical et dentaireLocation: LEZIGNEUX (42600), Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
EURL LABORATOIRE SERGE GAGNAIRE is a French company
founded 23 years ago,
specialized in the sector Fabrication de matériel médico-chirurgical et dentaire.
Based in LEZIGNEUX (42600),
this company of category PME
shows in 2025 a net income positive of 65 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EURL LABORATOIRE SERGE GAGNAIRE (SIREN 444709042)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
65 116 €
-31 214 €
65 042 €
71 924 €
60 526 €
71 435 €
8 723 €
-8 132 €
56 223 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, EURL LABORATOIRE SERGE GAGNAIRE generates positive net income of 65 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 56 k€ -> 65 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
65 116 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 8%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
7.814%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
58.332%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
80.087
52.082
38.808
26.808
51.556
35.675
26.095
51.411
7.814
Financial autonomy
45.071
53.575
53.356
58.952
52.249
55.342
58.498
41.81
58.332
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
7.812025
2023
2024
2025
Q1: 5.49
Med: 17.07
Q3: 41.92
Good-21 pts over 3 years
In 2025, the debt ratio of EURL LABORATOIRE SERGE GA... (7.81) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
58.33%2025
2023
2024
2025
Q1: 36.67%
Med: 56.53%
Q3: 69.09%
Good-11 pts over 3 years
In 2025, the financial autonomy of EURL LABORATOIRE SERGE GA... (58.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 248.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
295.652
293.321
228.867
268.26
301.759
279.943
301.57
213.432
248.161
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
248.162025
2023
2024
2025
Q1: 181.98
Med: 251.18
Q3: 365.98
Average-9 pts over 3 years
In 2025, the liquidity ratio of EURL LABORATOIRE SERGE GA... (248.16) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of EURL LABORATOIRE SERGE GAGNAIRE in its sector
Comparison with sector Fabrication de matériel médico-chirurgical et dentaire
Valuation estimate
Based on 57 transactions of similar company sales
(all years),
the value of EURL LABORATOIRE SERGE GAGNAIRE is estimated at
198 322 €
(range 46 087€ - 391 083€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2025
57 tx
46k€198k€391k€
198 322 €Range: 46 087€ - 391 083€
NAF 5 all-time
Valuation method used
Net Income Multiple
65 116 €
×
3.0x
=198 323 €
Range: 46 088€ - 391 083€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fabrication de matériel médico-chirurgical et dentaire)
Compare EURL LABORATOIRE SERGE GAGNAIRE with other companies in the same sector:
Frequently asked questions about EURL LABORATOIRE SERGE GAGNAIRE
What is the revenue of EURL LABORATOIRE SERGE GAGNAIRE ?
The revenue of EURL LABORATOIRE SERGE GAGNAIRE is not publicly disclosed (confidential accounts filed with INPI).
Is EURL LABORATOIRE SERGE GAGNAIRE profitable?
Yes, EURL LABORATOIRE SERGE GAGNAIRE generated a net profit of 65 k€ in 2025.
Where is the headquarters of EURL LABORATOIRE SERGE GAGNAIRE ?
The headquarters of EURL LABORATOIRE SERGE GAGNAIRE is located in LEZIGNEUX (42600), in the department Loire.
Where to find the tax return of EURL LABORATOIRE SERGE GAGNAIRE ?
The tax return of EURL LABORATOIRE SERGE GAGNAIRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EURL LABORATOIRE SERGE GAGNAIRE operate?
EURL LABORATOIRE SERGE GAGNAIRE operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart